nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00087	0.00087	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00087	0.00087	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—COL9A1—osteoarthritis	0.000855	0.000855	CbGpPWpGaD
Erlotinib—MKNK1—Disease—SMAD3—osteoarthritis	0.000854	0.000854	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—MMP9—osteoarthritis	0.000852	0.000852	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—MMP3—osteoarthritis	0.000844	0.000844	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—TGFB1—osteoarthritis	0.000833	0.000833	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	0.000831	0.000831	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—MMP9—osteoarthritis	0.000831	0.000831	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—SMAD3—osteoarthritis	0.000816	0.000816	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—FMOD—osteoarthritis	0.000807	0.000807	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000796	0.000796	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—TGFB1—osteoarthritis	0.00079	0.00079	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—TNF—osteoarthritis	0.000777	0.000777	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGES—osteoarthritis	0.000775	0.000775	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—IL1B—osteoarthritis	0.000766	0.000766	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HSPA5—osteoarthritis	0.00075	0.00075	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000743	0.000743	CbGpPWpGaD
Erlotinib—EPHA6—Axon guidance—IL6—osteoarthritis	0.000741	0.000741	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	0.00074	0.00074	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—TNF—osteoarthritis	0.000737	0.000737	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.000737	0.000737	CbGpPWpGaD
Erlotinib—UGT1A1—NRF2 pathway—TGFB1—osteoarthritis	0.000733	0.000733	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL1A—osteoarthritis	0.000729	0.000729	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGES—osteoarthritis	0.000723	0.000723	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—BMP2—osteoarthritis	0.000719	0.000719	CbGpPWpGaD
Erlotinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.00071	0.00071	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.000707	0.000707	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—TGFB1—osteoarthritis	0.000702	0.000702	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—SMAD3—osteoarthritis	0.000694	0.000694	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFBI—osteoarthritis	0.000686	0.000686	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000681	0.000681	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—TNF—osteoarthritis	0.000676	0.000676	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000676	0.000676	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000671	0.000671	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CTSK—osteoarthritis	0.000669	0.000669	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CAMK2B—osteoarthritis	0.000669	0.000669	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—ESR1—osteoarthritis	0.000666	0.000666	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—MMP2—osteoarthritis	0.000665	0.000665	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP3—osteoarthritis	0.000661	0.000661	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGES—osteoarthritis	0.000658	0.000658	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—TNF—osteoarthritis	0.000656	0.000656	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MCF2L—osteoarthritis	0.000644	0.000644	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IHH—osteoarthritis	0.000644	0.000644	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000637	0.000637	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000631	0.000631	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000631	0.000631	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000629	0.000629	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—IL6—osteoarthritis	0.000627	0.000627	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—TGFB1—osteoarthritis	0.000621	0.000621	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CRP—osteoarthritis	0.000609	0.000609	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—MMP1—osteoarthritis	0.000602	0.000602	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SMAD3—osteoarthritis	0.000598	0.000598	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.000595	0.000595	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—IL6—osteoarthritis	0.000595	0.000595	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—LEP—osteoarthritis	0.000593	0.000593	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—SMAD3—osteoarthritis	0.000593	0.000593	CbGpPWpGaD
Erlotinib—EGFR—Disease—GSTO1—osteoarthritis	0.000593	0.000593	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	0.000591	0.000591	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000587	0.000587	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—BMP2—osteoarthritis	0.000586	0.000586	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—FMOD—osteoarthritis	0.000578	0.000578	CbGpPWpGaD
Erlotinib—EGFR—Disease—BGN—osteoarthritis	0.000574	0.000574	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CTSK—osteoarthritis	0.000572	0.000572	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CAMK2B—osteoarthritis	0.000572	0.000572	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—MMP2—osteoarthritis	0.000568	0.000568	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—TGFB1—osteoarthritis	0.000563	0.000563	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TNF—osteoarthritis	0.000556	0.000556	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000549	0.000549	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—FN1—osteoarthritis	0.000549	0.000549	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—IL6—osteoarthritis	0.000546	0.000546	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—FMOD—osteoarthritis	0.000546	0.000546	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GSTO1—osteoarthritis	0.000546	0.000546	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—IL6—osteoarthritis	0.000546	0.000546	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000537	0.000537	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	0.000537	0.000537	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CRP—osteoarthritis	0.000536	0.000536	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HSPA5—osteoarthritis	0.000533	0.000533	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—IL6—osteoarthritis	0.000529	0.000529	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—BGN—osteoarthritis	0.000529	0.000529	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.000524	0.000524	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000523	0.000523	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1RN—osteoarthritis	0.000518	0.000518	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—IL6—osteoarthritis	0.000516	0.000516	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.000513	0.000513	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—LEP—osteoarthritis	0.000511	0.000511	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GSTO1—osteoarthritis	0.000509	0.000509	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—LEP—osteoarthritis	0.000507	0.000507	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000502	0.000502	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—FMOD—osteoarthritis	0.000501	0.000501	CbGpPWpGaD
Erlotinib—MKNK1—Disease—PTGS2—osteoarthritis	0.0005	0.0005	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—HSPA5—osteoarthritis	0.0005	0.0005	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—MMP9—osteoarthritis	0.0005	0.0005	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP3—osteoarthritis	0.000498	0.000498	CbGpPWpGaD
Erlotinib—ALB—Metabolism—FMOD—osteoarthritis	0.000498	0.000498	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000494	0.000494	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—BGN—osteoarthritis	0.000493	0.000493	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—ESR1—osteoarthritis	0.000488	0.000488	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—IL6—osteoarthritis	0.000486	0.000486	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—FN1—osteoarthritis	0.000482	0.000482	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—IGF1—osteoarthritis	0.000481	0.000481	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CXCL8—osteoarthritis	0.000478	0.000478	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TIMP1—osteoarthritis	0.000476	0.000476	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP2—osteoarthritis	0.000475	0.000475	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—COL9A2—osteoarthritis	0.000473	0.000473	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGES—osteoarthritis	0.000471	0.000471	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—IL6—osteoarthritis	0.000464	0.000464	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GSTO1—osteoarthritis	0.000463	0.000463	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—IL6—osteoarthritis	0.000462	0.000462	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB2—IL6—osteoarthritis	0.00046	0.00046	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000459	0.000459	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—COL9A1—osteoarthritis	0.000459	0.000459	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CRP—osteoarthritis	0.000458	0.000458	CbGpPWpGaD
Erlotinib—EGFR—DAP12 signaling—IL6—osteoarthritis	0.000457	0.000457	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HSPA5—osteoarthritis	0.000455	0.000455	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000452	0.000452	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SMAD3—osteoarthritis	0.000451	0.000451	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—BGN—osteoarthritis	0.000449	0.000449	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGES—osteoarthritis	0.000445	0.000445	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1RN—osteoarthritis	0.000443	0.000443	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—FMOD—osteoarthritis	0.000436	0.000436	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CXCL8—osteoarthritis	0.000434	0.000434	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	0.000433	0.000433	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—IL6—osteoarthritis	0.00043	0.00043	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.00043	0.00043	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—IL6—osteoarthritis	0.00043	0.00043	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—MMP9—osteoarthritis	0.000427	0.000427	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—IL6—osteoarthritis	0.000426	0.000426	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000423	0.000423	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IGF1—osteoarthritis	0.000422	0.000422	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—IL6—osteoarthritis	0.000421	0.000421	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—FMOD—osteoarthritis	0.000411	0.000411	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000408	0.000408	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP3—osteoarthritis	0.000406	0.000406	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGES—osteoarthritis	0.000406	0.000406	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP2—osteoarthritis	0.000406	0.000406	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—LEP—osteoarthritis	0.000386	0.000386	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000381	0.000381	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL1B—osteoarthritis	0.00038	0.00038	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000375	0.000375	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1A—osteoarthritis	0.000373	0.000373	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—MMP3—osteoarthritis	0.000369	0.000369	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000368	0.000368	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—ESR1—osteoarthritis	0.000368	0.000368	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SMAD3—osteoarthritis	0.000368	0.000368	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—FN1—osteoarthritis	0.000364	0.000364	CbGpPWpGaD
Erlotinib—MKNK1—Disease—TGFB1—osteoarthritis	0.000362	0.000362	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP9—osteoarthritis	0.000357	0.000357	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGES—osteoarthritis	0.000356	0.000356	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—FMOD—osteoarthritis	0.000348	0.000348	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CXCL8—osteoarthritis	0.00034	0.00034	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000335	0.000335	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GSTO1—osteoarthritis	0.000332	0.000332	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—BGN—osteoarthritis	0.000322	0.000322	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1A—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IGF1—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000318	0.000318	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—BMP2—osteoarthritis	0.000315	0.000315	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—LEP—osteoarthritis	0.000314	0.000314	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GSTO1—osteoarthritis	0.000314	0.000314	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CRP—osteoarthritis	0.000312	0.000312	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—IL6—osteoarthritis	0.00031	0.00031	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP9—osteoarthritis	0.000307	0.000307	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP9—osteoarthritis	0.000305	0.000305	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—BGN—osteoarthritis	0.000304	0.000304	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ESR1—osteoarthritis	0.0003	0.0003	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—FN1—osteoarthritis	0.000296	0.000296	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—MMP1—osteoarthritis	0.000296	0.000296	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TGFB1—osteoarthritis	0.000294	0.000294	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—IL6—osteoarthritis	0.000293	0.000293	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TGFB1—osteoarthritis	0.000288	0.000288	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GSTO1—osteoarthritis	0.000288	0.000288	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GSTO1—osteoarthritis	0.000286	0.000286	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGES—osteoarthritis	0.000284	0.000284	CbGpPWpGaD
Erlotinib—EGFR—Disease—SMAD3—osteoarthritis	0.000282	0.000282	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—BGN—osteoarthritis	0.000278	0.000278	CbGpPWpGaD
Erlotinib—ALB—Metabolism—BGN—osteoarthritis	0.000277	0.000277	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000275	0.000275	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—osteoarthritis	0.000274	0.000274	CbGpPWpGaD
Erlotinib—MKNK1—Disease—IL6—osteoarthritis	0.000273	0.000273	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000271	0.000271	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—FN1—osteoarthritis	0.00027	0.00027	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000269	0.000269	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CRP—osteoarthritis	0.000267	0.000267	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—IL6—osteoarthritis	0.000265	0.000265	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IGF1—osteoarthritis	0.00026	0.00026	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CXCL8—osteoarthritis	0.000256	0.000256	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFB1—osteoarthritis	0.000253	0.000253	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000253	0.000253	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TGFB1—osteoarthritis	0.000251	0.000251	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTO1—osteoarthritis	0.000251	0.000251	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL6—osteoarthritis	0.000244	0.000244	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—BGN—osteoarthritis	0.000243	0.000243	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IGF1—osteoarthritis	0.000237	0.000237	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTO1—osteoarthritis	0.000236	0.000236	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—osteoarthritis	0.000235	0.000235	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP9—osteoarthritis	0.000232	0.000232	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—BGN—osteoarthritis	0.000229	0.000229	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—osteoarthritis	0.000223	0.000223	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—osteoarthritis	0.000222	0.000222	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000219	0.000219	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP3—osteoarthritis	0.000218	0.000218	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL8—osteoarthritis	0.000209	0.000209	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTO1—osteoarthritis	0.0002	0.0002	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SMAD3—osteoarthritis	0.000197	0.000197	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000196	0.000196	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—osteoarthritis	0.000196	0.000196	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—osteoarthritis	0.000195	0.000195	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—BGN—osteoarthritis	0.000194	0.000194	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—osteoarthritis	0.000191	0.000191	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—osteoarthritis	0.000191	0.000191	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL8—osteoarthritis	0.00019	0.00019	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00018	0.00018	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000179	0.000179	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LEP—osteoarthritis	0.000169	0.000169	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—osteoarthritis	0.000167	0.000167	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—osteoarthritis	0.000166	0.000166	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—osteoarthritis	0.000165	0.000165	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ESR1—osteoarthritis	0.000161	0.000161	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—FN1—osteoarthritis	0.000159	0.000159	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—osteoarthritis	0.000156	0.000156	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000154	0.000154	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—osteoarthritis	0.000152	0.000152	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—BGN—osteoarthritis	0.000149	0.000149	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—osteoarthritis	0.000144	0.000144	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—osteoarthritis	0.000142	0.000142	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—osteoarthritis	0.000142	0.000142	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IGF1—osteoarthritis	0.000139	0.000139	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—osteoarthritis	0.000129	0.000129	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000125	0.000125	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—osteoarthritis	0.000119	0.000119	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—osteoarthritis	0.000117	0.000117	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—osteoarthritis	0.000114	0.000114	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—osteoarthritis	0.000112	0.000112	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—osteoarthritis	0.000107	0.000107	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—osteoarthritis	0.000101	0.000101	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—osteoarthritis	9.74e-05	9.74e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—osteoarthritis	9.24e-05	9.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—osteoarthritis	8.99e-05	8.99e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—osteoarthritis	8.73e-05	8.73e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—osteoarthritis	8.35e-05	8.35e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—osteoarthritis	8.01e-05	8.01e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—osteoarthritis	7.96e-05	7.96e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—osteoarthritis	6.97e-05	6.97e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—osteoarthritis	6.57e-05	6.57e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—osteoarthritis	6.3e-05	6.3e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—osteoarthritis	5.57e-05	5.57e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—osteoarthritis	4.3e-05	4.3e-05	CbGpPWpGaD
